Tokyo, Nov. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059867) titled 'Diabetic peripheral neuropathy as an independent predictor of renal function decline in type 2 diabetes: a propensity score-matched retrospective cohort study using DPN-Check' on Nov. 24.
Study Type:
Observational
Primary Sponsor:
Institute - Edogawa Hospital
Condition:
Condition - Type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the impact of diabetic peripheral neuropathy on subsequent changes in renal function in patients with type 2 diabetes.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Japanese patients with type 2 diabetes who did not have foot ulcers and underwent nerve conduction assessment using DPN-Check between June 2015 and April 2017.
Key exclusion criteria - Patients who were transferred to another medical institution or discontinued treatment within 5 years of the start of observation, and those who died due to unknown causes or unrelated to kidney disease
Target Size - 400
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 08 Month 06 Day
Date of IRB - 2025 Year 08 Month 06 Day
Anticipated trial start date - 2025 Year 08 Month 06 Day
Last follow-up date - 2025 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068460
Disclaimer: Curated by HT Syndication.
